HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
CB 181963
structure in first source
Also Known As:
CAB 175; CAB-175; CAB175; CB-181963; CB181963
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Amides: 2428
Lactams: 2198
beta-Lactams: 2386
Cephalosporins: 4007
CB 181963: 1
Sulfur Compounds: 278
Thiazines: 3
Cephalosporins: 4007
CB 181963: 1
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
beta-Lactams: 2386
Cephalosporins: 4007
CB 181963: 1
Experts
1.
Chopra, Ian
: 1 article (04/2005)
2.
Hobbs, Joanne K
: 1 article (04/2005)
3.
Hoyle, Anthony M
: 1 article (04/2005)
4.
Miller, Keith
: 1 article (04/2005)
5.
Storey, Christopher
: 1 article (04/2005)
6.
Stubbings, William J
: 1 article (04/2005)
Related Diseases
1.
Staphylococcal Infections
04/01/2005 - "
CB-181963 may have a role in the treatment of staphylococcal infections, including those caused by MRSA and in the prophylaxis of biofilm-associated MSSA and MRSA infections.
"
2.
Infections
04/01/2005 - "
CB-181963 may have a role in the treatment of staphylococcal infections, including those caused by MRSA and in the prophylaxis of biofilm-associated MSSA and MRSA infections.
"